Tanya Nagy
Physician Assistant · Spartanburg, SCNPI 1447527205
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $15,361 of the $23,274 with a category attached, or 66.0%. It is spread thinly across 38 manufacturers, the largest accounting for just 23.8%. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 586 payments — averaging $39.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Dexcom, Inc.$3K
- Mannkind Corporation$3K
- Novo Nordisk$2K
- Abbott$2K
- Lilly USA, LLC$1K
- plus $6K from 32 others
What the payments were for
- Consulting fees$1,2755%
- Speaking & faculty fees$1,6287%
- Travel & lodging$4,68720%
- Food & beverage$15,36166%
- Education$3231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 64 | $5,531 |
| Dexcom, Inc. | 77 | $2,866 |
| Mannkind Corporation | 9 | $2,539 |
| Novo Nordisk | 98 | $2,479 |
| Abbott | 95 | $1,988 |
| Lilly USA, LLC | 89 | $1,461 |
| Insulet Corporation | 19 | $788 |
| Sanofi-aventis U.S. LLC | 21 | $709 |
| Amgen(2 entities) | 24 | $695 |
| Ascensia Diabetes Care US Inc. | 4 | $468 |
| BETA Bionics, Inc. | 3 | $458 |
| AstraZeneca | 10 | $443 |
| Boehringer Ingelheim | 15 | $362 |
| Intuity Medical Inc | 5 | $323 |
| Xeris Pharmaceuticals, Inc. | 13 | $314 |
| Cequr Corporation | 2 | $248 |
| Gilead | 2 | $212 |
| Radius Health, Inc. | 5 | $200 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $125 |
| Akcea Therapeutics, Inc. | 1 | $124 |
| Phathom Pharmaceuticals, Inc. | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $116 |
| Neurelis, Inc. | 1 | $112 |
| Pfizer | 1 | $108 |
| Amneal Pharmaceuticals LLC | 4 | $95 |
| AbbVie | 3 | $55 |
| Amarin Pharma, Inc. | 3 | $51 |
| Ascendis Pharma Endocrinology Inc | 2 | $49 |
| Sequel Med Tech, LLC | 2 | $40 |
| Bayer | 2 | $38 |
| Nevro Corp. | 1 | $30 |
| Lifescan, Inc. | 2 | $25 |
| Novartis | 1 | $24 |
| IBSA Pharma Inc. | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Globus Medical | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFREZZA$2,396
- MINIMED 780G$2,131
- DEXCOM G7 GSS (161)$2,015
- MINIMED 770G$1,628
- iLet Bionic Pancreas$1,283
- DEXCOM STELO GLUCOSE BIOSENSOR$1,011
- Repatha$338
- FREESTYLE LIBRE 3$249
- CeQur Simplicity$248
- FARXIGA$235
- INPEN SMART INSULIN DELIVERY SYSTEM$131
- SOLIQUA 100/33$127
- XIFAXAN$125
- TEGSEDI$124
- DEXCOM G6 TRANSMITTER$123
- ZEPBOUND$123
- VOQUEZNA$120
- Auvelity$116
- Ozempic$114
- Epclusa$113
How this compares
$23,274 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 181 | $247,241 |
| Tresiba Flextouch U-200Insulin Degludec | 117 | $154,974 |
| MounjaroTirzepatide | 97 | $148,794 |
| JardianceEmpagliflozin | 124 | $141,238 |
| FarxigaDapagliflozin Propanediol | 121 | $112,184 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 51 | $84,317 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 43 | $82,639 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 89 | $63,884 |
| Tresiba Flextouch U-100Insulin Degludec | 90 | $63,479 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 34 | $57,771 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 43 | $53,879 |
| TrulicityDulaglutide | 42 | $51,902 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 25 | $35,897 |
| Novolog FlexpenInsulin Aspart | 111 | $34,549 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 26 | $31,759 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $2,479 | $261,247222 claims |
| Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog | $1,461 | $241,861213 claims |
| Boehringer IngelheimJardiance | $362 | $141,238124 claims |
| AstraZenecaFarxiga | $443 | $112,184121 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $709 | $36,78853 claims |
| MerckJanumet, Janumet Xr | $16 | $15,28424 claims |
| PfizerLyrica, Levoxyl | $108 | $8,71951 claims |
| AbbVieSynthroid | $55 | $4,83751 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $95 | $1,628155 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Spartanburg
- Ainsley WingardSpartanburg$16K
- Jian WuSpartanburg$10K
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
- Eric ShoupColumbia$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.